Skip to content
Resources > Reports

AlphaSense Market Report by TrustRadius

In the high-stakes world of financial and market research, fragmented information wastes time and costs opportunities. Traditional market intelligence platforms are cumbersome, making it challenging to access critical insights when they matter most.

As a 2025 Buyer’s Choice Award winner on TrustRadius, AlphaSense delivers a seamless and comprehensive research experience, blending cutting-edge AI with an intuitive interface designed for quick, data-driven decision-making.

Read the TrustRadius report to learn why top financial firms and corporations choose AlphaSense, including:

  • Vast Data Access:Consolidates a huge library of information into one easy-to-use platform.
  • AI-Driven Efficiency:Sentiment analysis and real-time alerts help surface critical insights faster.
  • Intuitive Interface:No complex training required—just quick, actionable results.

Proven Success:

  • 100% of TrustRadius reviewers would buy AlphaSense again.
  • 99% say it delivers excellent value for the price.

Explore more

APAC Macro Briefing 2026: Risk Meets Opportunity

In this report, we show how resources and workflows available in the AlphaSense platform can help contextualize the APAC macro environment, exploring the key implications for corporate leaders and investors across sectors.
Title slide for "APAC Macro Briefing 2026: Risk Meets Opportunity" with a map of the Asia-Pacific region.

Top AI Use Cases for Private Equity

In this report, discover how private equity teams are leveraging AI to accelerate conviction with speed. With purpose built, AI-driven solutions like AlphaSense, teams are gaining a competitive advantage with custom workflows and unmatched content sets for the most differentiated deal intelligence.
Top AI Use Cases For Private Equity by Barb Tague, Financial Research Leader. Illustration featuring isometric buildings and currency symbols.

AI in Drug Development 2026: From Experimentation to Execution

Learn how AI is reshaping drug development in real time, turning AI execution into a key competitive differentiator.
Presentation slide titled "AI in Drug Development 2026: From Experimentation to Execution" by Sara Mallatt and Sean Carmichael, with line art of laboratory equipment.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.